A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer

Clinical trial NCT00190489 · COMPLETED

Trial details

NCT number: NCT00190489
Sponsor: Japan Clinical Oncology Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Neoplasm Metastasis

Start date: 1999-01-01
Primary completion: 2006-05-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.